Gradient Dissent - A Machine Learning Podcast avatar

Dexa/Gradient Dissent - A Machine Learning Podcast

Learn more
Published Aug 26, 2021

Jeff Hammerbacher — From data science to biomedicine

Jeff Hammerbacher shares his transformative journey from pioneering data science at Facebook, co-founding Cloudera, to revolutionizing biomedicine with innovative approaches in cancer therapy at Related Sciences, showcasing his commitment to harnessing data for groundbreaking advancements.
Episode Highlights
Gradient Dissent - A Machine Learning Podcast logo

Topics covered

Popular Clips

Episode Highlights

  • Career Shift

    shares his remarkable transition from data science to biomedicine, driven by a desire to find a domain where he wouldn't tire of the subject matter. At Cloudera, he realized the limitations of existing technical infrastructure in biomedicine and saw an opportunity to apply his data science expertise to this expansive field 1. Jeff's journey led him to establish a lab in New York City, initially focusing on computational work but eventually expanding to include a wet lab for more comprehensive research 2.

    I really wanted to focus on finding a domain where I could do data science and not get bored of the entities under analysis.

    ---

    His lab's transformation reflects his commitment to advancing biomedicine through innovative data-driven approaches.

       

    Biotech Innovations

    In the realm of biomedicine, has made significant strides with his work on immune checkpoint blockade and neoantigen vaccines. The immune checkpoint blockade, a groundbreaking cancer therapy, involves preventing cancer cells from deactivating T cells, thereby enhancing the immune response against tumors 3. Jeff's involvement in developing neoantigen vaccines further showcases his innovative approach, as these therapeutic vaccines are tailored to stimulate an immune response specific to an individual's tumor mutations 4.

    Perhaps that would cause the immune response to cancer to fully eradicate the tumor.

    ---

    These projects highlight his dedication to leveraging data science for transformative cancer treatments.

       

    Related Sciences

    co-founded Related Sciences, a biotech venture creation firm, to further his vision of advancing biomedicine through data-driven methods. The firm focuses on identifying promising preclinical therapeutic opportunities and creating companies to pursue these innovations 2. Jeff's experience in academia and industry has shaped his approach, emphasizing the importance of owning vertical research ideas for effective collaboration 5.

    The idea of related sciences is to use data to identify promising preclinical therapeutic opportunities.

    ---

    His work at Related Sciences underscores his commitment to bridging the gap between data science and biomedicine.

Related Episodes